Sun Pharma gets DCGI nod to make, market generic semaglutide injection in India for weight management
Image used for representation purpose only. | Photo Credit: Reuters Sun Pharmaceutical Industries Ltd said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct…